What really has sold me is the fact that Bisantrene is a proven phase II/III drug that has shown efficacy. I don’t know any other ASX listed company with this type of asset under its belt. All we need is to apply the asset to modern day patients and get brand new data and we are sitting on a gold mine. In other words, we know the mine has gold (Bisantrene) in it but all we got to do is prove it is still there in 2021.
Ann: Change in substantial holding, page-62
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.000(0.00%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.66 | $1.60 | $207.2K | 127.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 25510 | $1.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.64 | 12000 | 1 |
View Market Depth
| Last trade - 15.49pm 29/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |